首页> 外文OA文献 >Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).

【2h】

Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).

机译：ripogrel的随机试验，组合血栓素A2合酶抑制剂和血栓素A2 /前列腺内氧化钠受体拮抗剂，阿司匹林与急性心肌梗死患者溶栓栓塞。 ridogrel与阿司匹林通畅试验（RAPT）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 1994
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat. [J] . Quest DW, Wilson TW Japanese Journal of Pharmacology . 1998,第4期

机译：血栓烷合酶抑制剂和受体拮抗剂利多雷尔对自发性高血压大鼠血压的影响。
2. Effects of Ridogrel, a Thromboxane Synthase Inhibitor and Receptor Antagonist, on Blood Pressure in the Spontaneously Hypertensive Rat [J] . Dale W. Quest, Thomas W. Wilson Japanese Journal of Pharmacology . 1998,第4期

机译：血氧烷合酶抑制剂和受体拮抗剂利多瑞尔对自发性高血压大鼠血压的影响
3. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. [J] . Fontana P, Alberts P, Sakariassen KS, Journal of thrombosis and haemostasis: JTH . 2011,第10期

机译：双重血栓烷受体拮抗剂和血栓烷合酶抑制剂EV-077是比阿司匹林更有效的血小板功能抑制剂。
4. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. [O] . P Golino, M Rosolowsky, S K Yao, 1990

机译：内源性前列腺素内过氧化物和前列环素可调节组织纤溶酶原激活物的溶栓活性。同时抑制血栓烷A2合酶和阻断血栓烷A2 /前列腺素H2受体在犬冠状动脉血栓形成模型中的作用。
5. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin [O] . B Hoet, C Falcon, S De Reys, 1990

机译：R68070，组合的血栓素/内透铁氧化钠受体拮抗剂和血栓素合成酶抑制剂，抑制体外和体内人的血小板活化：与阿司匹林的比较

Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).

著录项

引文网络

相似文献

相关主题

期刊订阅